📣 VC round data is live. Check it out!
- Public Comps
- Qingdao Baheal Medical
Qingdao Baheal Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Qingdao Baheal Medical and similar public comparables like UFP Technologies, Pulse Biosciences, Beijing Balance Medical, Heron Neutron Medical and more.
Qingdao Baheal Medical Overview
About Qingdao Baheal Medical
Qingdao Baheal Medical Inc is engaged in providing comprehensive marketing services for pharmaceutical product manufacturers.
Founded
2005
HQ

Employees
N/A
Website
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialQingdao Baheal Medical Financials
Qingdao Baheal Medical reported last 12-month revenue of $1B and EBITDA of $140M.
In the same LTM period, Qingdao Baheal Medical generated $423M in gross profit, $140M in EBITDA, and $83M in net income.
Revenue (LTM)
Qingdao Baheal Medical P&L
In the most recent fiscal year, Qingdao Baheal Medical reported revenue of $1B and EBITDA of $140M.
Qingdao Baheal Medical is profitable as of last fiscal year, with gross margin of 37%, EBITDA margin of 13%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Qingdao Baheal Medical Stock Performance
Qingdao Baheal Medical has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Qingdao Baheal Medical's stock price is $3.22.
Qingdao Baheal Medical share price decreased by 2.3% in the last 30 days, and increased by 10.7% in the last year.
Qingdao Baheal Medical has an EPS (earnings per share) of $0.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -2.3% | -2.3% | -8.7% | 10.7% | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialQingdao Baheal Medical Valuation Multiples
Qingdao Baheal Medical trades at 1.6x EV/Revenue multiple, and 13.2x EV/EBITDA.
EV / Revenue (LTM)
Qingdao Baheal Medical Financial Valuation Multiples
As of June 2, 2026, Qingdao Baheal Medical has market cap of $2B and EV of $2B.
Qingdao Baheal Medical has a P/E ratio of 20.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Qingdao Baheal Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Qingdao Baheal Medical Margins & Growth Rates
Qingdao Baheal Medical grew revenue by 7% and EBITDA by 15% in the last fiscal year.
In the most recent fiscal year, Qingdao Baheal Medical reported gross margin of 37%, EBITDA margin of 13%, and net margin of 6%.
Qingdao Baheal Medical Margins
Qingdao Baheal Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Qingdao Baheal Medical Operational KPIs
Qingdao Baheal Medical's Rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Qingdao Baheal Medical's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Qingdao Baheal Medical Competitors
Qingdao Baheal Medical competitors include UFP Technologies, Pulse Biosciences, Beijing Balance Medical, Heron Neutron Medical, Zydus Wellness, Faes Farma, MicroPort EP, BoneSupport, Draegerwerk and Embla Medical.
Most Qingdao Baheal Medical public comparables operate across Health & Beauty, Healthcare Software, Medical Devices, B2B SaaS, BioTech, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.0x | 2.9x | 15.1x | 14.5x | |||
| 4708.5x | 1081.6x | (32.7x) | (29.2x) | |||
| 18.4x | - | 45.8x | - | |||
| 4066.5x | - | (95.0x) | - | |||
| 4.8x | 4.5x | 37.3x | 34.0x | |||
| 2.7x | 2.5x | 14.1x | 12.6x | |||
| 22.8x | 21.5x | 120.1x | 113.6x | |||
| 12.3x | 11.0x | 59.4x | 45.6x | |||
This data is available for Pro users. Sign up to see all Qingdao Baheal Medical competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Qingdao Baheal Medical
| When was Qingdao Baheal Medical founded? | Qingdao Baheal Medical was founded in 2005. |
| Where is Qingdao Baheal Medical headquartered? | Qingdao Baheal Medical is headquartered in China. |
| Is Qingdao Baheal Medical publicly listed? | Yes, Qingdao Baheal Medical is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Qingdao Baheal Medical? | Qingdao Baheal Medical trades under 301015 ticker. |
| When did Qingdao Baheal Medical go public? | Qingdao Baheal Medical went public in 2021. |
| Who are competitors of Qingdao Baheal Medical? | Qingdao Baheal Medical main competitors include UFP Technologies, Pulse Biosciences, Beijing Balance Medical, Heron Neutron Medical, Zydus Wellness, Faes Farma, MicroPort EP, BoneSupport, Draegerwerk, Embla Medical. |
| What is the current market cap of Qingdao Baheal Medical? | Qingdao Baheal Medical's current market cap is $2B. |
| What is the current revenue of Qingdao Baheal Medical? | Qingdao Baheal Medical's last 12 months revenue is $1B. |
| What is the current revenue growth of Qingdao Baheal Medical? | Qingdao Baheal Medical revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Qingdao Baheal Medical? | Current revenue multiple of Qingdao Baheal Medical is 1.6x. |
| What is the current EBITDA of Qingdao Baheal Medical? | Qingdao Baheal Medical's last 12 months EBITDA is $140M. |
| What is Qingdao Baheal Medical's EBITDA margin? | Qingdao Baheal Medical's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Qingdao Baheal Medical? | Current EBITDA multiple of Qingdao Baheal Medical is 13.2x. |
| How many companies Qingdao Baheal Medical has acquired to date? | Qingdao Baheal Medical hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Qingdao Baheal Medical has invested to date? | Qingdao Baheal Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Qingdao Baheal Medical
Lists including Qingdao Baheal Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.